These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus. Wang WM; Wang KY; Wang T; Jin HZ; Fang K Chin Med J (Engl); 2018 Aug; 131(15):1887-1888. PubMed ID: 30058593 [No Abstract] [Full Text] [Related]
23. Retinal toxicity found in a patient with systemic lupus erythematosus prior to 5 years of treatment with hydroxychloroquine. Chiang E; Jampol LM; Fawzi AA Rheumatology (Oxford); 2014 Nov; 53(11):2001. PubMed ID: 25172940 [No Abstract] [Full Text] [Related]
24. [Quinacrine in the treatment of cutaneous lupus erythematosus: practical aspects and a case series]. González-Sixto B; García-Doval I; Oliveira R; Posada C; García-Cruz MA; Cruces M Actas Dermosifiliogr; 2010; 101(1):54-8. PubMed ID: 20109393 [TBL] [Abstract][Full Text] [Related]
25. [Acute generalized exanthematous pustulosis included by hydroxychloroquine during lupus]. Fain O; Stirnemann J; Kettaneh A Rev Prat; 2010 Jan; 60(1):20. PubMed ID: 20222305 [No Abstract] [Full Text] [Related]
26. Hydroxychloroquine-induced erythroderma. Pai SB; Sudershan B; Kuruvilla M; Kamath A; Suresh PK Indian J Pharmacol; 2017; 49(1):132-134. PubMed ID: 28458440 [TBL] [Abstract][Full Text] [Related]
28. Case records of the Massachusetts General Hospital. Case 11-2011. A 47-year-old man with systemic lupus erythematosus and heart failure. Newton-Cheh C; Lin AE; Baggish AL; Wang H N Engl J Med; 2011 Apr; 364(15):1450-60. PubMed ID: 21488768 [No Abstract] [Full Text] [Related]
29. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases. Bahloul E; Jallouli M; Garbaa S; Marzouk S; Masmoudi A; Turki H; Bahloul Z Lupus; 2017 Oct; 26(12):1304-1308. PubMed ID: 28355984 [TBL] [Abstract][Full Text] [Related]
30. [The therapy of systemic lupus erythematosus]. Ochsendorf FR; Runne U Dtsch Med Wochenschr; 1997 Jul; 122(27):877. PubMed ID: 9280702 [No Abstract] [Full Text] [Related]
31. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 10. Hydroxychloroquine]. Yokogawa N Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2960-5. PubMed ID: 22175138 [No Abstract] [Full Text] [Related]
32. Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy. Comín-Colet J; Sánchez-Corral MA; Alegre-Sancho JJ; Valverde J; López-Gómez D; Sabaté X; Juan-Mas A; Esplugas E Lupus; 2001; 10(1):59-62. PubMed ID: 11243511 [TBL] [Abstract][Full Text] [Related]
33. Myasthenia gravis due to hydroxychloroquine. Varan O; Kucuk H; Tufan A Reumatismo; 2015 Dec; 67(3):849. PubMed ID: 26876193 [No Abstract] [Full Text] [Related]
34. Vesico-bullous subacute cutaneous lupus erythematosus--an uncommon entity successfully treated with dapsone and hydroxychloroquine. Pinto-Almeida T; Sanches M; Alves R; Selores M Dermatol Online J; 2012 Aug; 18(8):13. PubMed ID: 22948063 [TBL] [Abstract][Full Text] [Related]
35. Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients. Polanski JF; Tanaka EA; Barros H; Chuchene AG; Miguel PTG; Skare TL Laryngoscope; 2021 Mar; 131(3):E957-E960. PubMed ID: 32603516 [TBL] [Abstract][Full Text] [Related]
36. Successful treatment with hydroxychloroquine for systemic lupus erythematosus with cutaneous involvement accompanied by a xanthomatous reaction. Takezawa K; Ueda-Hayakawa I; Yamazaki F; Kambe N; Son Y; Okamoto H Lupus; 2020 Jan; 29(1):79-82. PubMed ID: 31789124 [TBL] [Abstract][Full Text] [Related]
37. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270 [TBL] [Abstract][Full Text] [Related]
38. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study. Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N; JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340 [TBL] [Abstract][Full Text] [Related]